About
MicroPort Endovastec, also known as Shanghai MicroPort Endovascular MedTech Group Co., Ltd., is a global medical device company based in Shanghai, China. Founded in 2012, it is a subsidiary of MicroPort Scientific Corporation and is publicly listed on the Shanghai STAR Market. The company focuses on the research, development, manufacturing, and sales of advanced devices for aortic and peripheral vascular interventions. The product range includes thoracic and abdominal aortic stent grafts, surgical stent grafts, peripheral vascular stents, and drug-coated percutaneous transluminal angioplasty (PTA) balloon catheters. These devices are designed to address vascular circulatory diseases, such as aortic aneurysms and peripheral vascular diseases. MicroPort Endovastec is dedicated to innovation, investing over 15% of its annual revenue into R&D and holding more than 230 patents globally. With a strong international presence, MicroPort Endovastec markets its products in over 28 countries and regions. The company aims to provide reliable access to advanced solutions for vascular diseases, enhancing patient care through innovative medical technologies.
Technologies
Keywords
Company Information
- Employees30
- Founded2012
Location
Shanghai, Shanghai, China
